Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Immunization Against Tumor Cells in Sezary Syndrome

This study has been completed.
Sponsor:
Information provided by:
FDA Office of Orphan Products Development
ClinicalTrials.gov Identifier:
NCT00099593
First received: December 17, 2004
Last updated: March 24, 2015
Last verified: December 2006
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: September 2007
  Estimated Primary Completion Date: No date given